Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
6(26%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
35%
Ph phase_3
1
4%
Ph phase_4
1
4%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

23

all time

Status Distribution
Active(8)
Completed(9)
Other(6)

Detailed Status

Completed9
unknown6
Recruiting4
Active, not recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
23
Active
6
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

active_not_recruiting29%
not_yet_recruiting29%
unknown626%
completed939%
recruiting417%

Recent Activity

6 active trials
Showing 5 of 23
recruitingnot_applicable

Structured Review: To Optimise Management and Prevent Harm in COPD

NCT07460154
not_yet_recruiting

Identification of B Regulatory Cells by Flow Cytometry

NCT06876506
recruiting

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

NCT06339190
completed

Sero-epidemiological Survey of England in 2019/2020 - COVID-19

NCT04061382
completed

P4 Peptide in Community Acquired Pneumonia

NCT03497962
View all 23 trials

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07460154Not Applicable

Structured Review: To Optimise Management and Prevent Harm in COPD

Recruiting
NCT06876506

Identification of B Regulatory Cells by Flow Cytometry

Not Yet Recruiting
NCT06339190

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Recruiting
NCT04061382

Sero-epidemiological Survey of England in 2019/2020 - COVID-19

Completed
NCT03497962

P4 Peptide in Community Acquired Pneumonia

Completed
NCT06444607

Hereditary Pheochromocytoma Assessment of Tumour Immunologies

Recruiting
NCT06648837Not Applicable

Microvisk Continuous Blood Donation Study

Not Yet Recruiting
NCT05403853Not Applicable

A Performance Evaluation of the Lumiradx Point of Care HbA1c Device

Completed
NCT04375982Not Applicable

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests

Unknown
NCT05180110Not Applicable

A Performance Evaluation of the LumiraDx Point of Care CRP Assay

Completed
NCT01171573

Investigating Genes in Patients With Polymyositis and Dermatomyositis

Active Not Recruiting
NCT03698084

RESCEU: Defining the Burden of RSV Disease

Active Not Recruiting
NCT04737954Not Applicable

A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay

Unknown
NCT03728595

Validation of a Predictive Score for HAST

Completed
NCT04493723

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

Recruiting
NCT02811068

Observational Follow up of Prior HPV Vaccinees

Completed
NCT03011658Not Applicable

Serum Cortisol Levels in Patients With Anxiety and Depression With Symptomatic Oral Lichen Planus

Completed
NCT02355730Not Applicable

Blood Donation From Warfarin Users for the Development of POC INR Monitor

Unknown
NCT01126996

Understanding the Persistence of Immunity After MenC Vaccines

Completed
NCT01546376

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Unknown

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
23